当前位置:首页 - 行情中心 - 前沿生物-U(688221) - 财务分析 - 现金流量表

前沿生物-U

(688221)

  

流通市值:40.27亿  总市值:40.27亿
流通股本:3.75亿   总股本:3.75亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金397,436,843.18380,302,958.52327,999,458.11112,281,305.46
  收到其他与经营活动有关的现金14,044,936.471,591,393.5879,609.887,410,314.69
  经营活动现金流入小计411,481,779.65381,894,352.02328,879,067.99119,691,620.15
  购买商品、接受劳务支付的现金27,272,565.417,530,594.0110,273,270.2147,258,975.4
  支付给职工以及为职工支付的现金91,470,741.1960,009,993.3335,522,873.18105,886,150.77
  支付的各项税费2,744,230.511,860,156.98893,005.93,215,140.46
  支付其他与经营活动有关的现金163,502,865.92121,604,642.0864,310,129.44189,919,656.29
  经营活动现金流出小计284,990,403.02201,005,386.4110,999,278.73346,279,922.92
  经营活动产生的现金流量净额126,491,376.63180,888,965.62217,879,789.26-226,588,302.77
二、投资活动产生的现金流量:
  取得投资收益收到的现金10,013,887.116,975,504.264,040,837.2712,222,334.51
  处置固定资产、无形资产和其他长期资产收回的现金净额1,391,529.41,391,409.430034,000
  处置子公司及其他营业单位收到的现金净额---27,473,375.34
  收到的其他与投资活动有关的现金1,860,426,0001,341,923,000647,700,0002,973,387,512.33
  投资活动现金流入小计1,871,831,416.511,350,289,913.66651,741,137.273,013,117,222.18
  购建固定资产、无形资产和其他长期资产支付的现金7,272,891.223,322,689.222,214,541.0529,864,170.78
  支付其他与投资活动有关的现金1,983,622,199.211,310,522,199.21910,066,4002,810,570,000
  投资活动现金流出小计1,990,895,090.431,313,844,888.43912,280,941.052,840,434,170.78
  投资活动产生的现金流量净额-119,063,673.9236,445,025.23-260,539,803.78172,683,051.4
三、筹资活动产生的现金流量:
  取得借款收到的现金251,658,756.4242,258,756.4142,258,756.4361,850,023.44
  筹资活动现金流入小计251,658,756.4242,258,756.4142,258,756.4361,850,023.44
  偿还债务支付的现金282,308,264228,641,80078,017,800362,623,796.37
  分配股利、利润或偿付利息支付的现金7,870,461.985,657,361.251,973,748.418,193,704.9
  支付其他与筹资活动有关的现金2,527,5282,468,1242,289,91215,455,433
  筹资活动现金流出小计292,706,253.98236,767,285.2582,281,460.41386,272,934.27
  筹资活动产生的现金流量净额-41,047,497.585,491,471.1559,977,295.99-24,422,910.83
四、汇率变动对现金及现金等价物的影响-329,438.4757,156.55-60,241.86-47,436.25
五、现金及现金等价物净增加额-33,949,233.34222,882,618.5517,257,039.61-78,375,598.45
  加:期初现金及现金等价物余额170,344,359.37170,344,359.37170,344,359.37248,719,957.82
  期末现金及现金等价物余额136,395,126.03393,226,977.92187,601,398.98170,344,359.37
补充资料:
  净利润-148,929,627.03--268,053,032.03
  资产减值准备-1,902,431.86-2,866,584.85
  固定资产和投资性房地产折旧-12,967,053.83-20,709,667.09
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-12,926,783.99-20,709,667.09
    投资性房地产折旧-40,269.84--
  无形资产摊销-10,706,566.44-21,616,253.3
  长期待摊费用摊销-490,454.36-589,964.8
  处置固定资产、无形资产和其他长期资产的损失--709,473.65-26,728.07
  固定资产报废损失-1,564.59-1,806.06
  公允价值变动损失--4,211,440.53-546,697.65
  财务费用-3,984,916.04-8,625,645.13
  投资损失--7,691,881.72-1,062,974.77
  存货的减少-2,331,544.55--19,113,212.28
  经营性应收项目的减少-9,503,821.11--27,872,292.61
  经营性应付项目的增加--7,169,437.8-5,831,261.21
  其他-7,993,265.75-3,595,045.86
  现金的期末余额-393,226,977.92-170,344,359.37
  减:现金的期初余额-170,344,359.37-248,719,957.82
  现金及现金等价物的净增加额-222,882,618.55--78,375,598.45
公告日期2026-10-312026-08-312026-04-252026-04-25
审计意见(境内)标准无保留意见
TOP↑